OLEMA PHARMACEUTICALS, INC. Common Stock, Capital Shares Reserved for Future Issuance
OLEMA PHARMACEUTICALS, INC. (OLMA) had Common Stock, Capital Shares Reserved for Future Issuance of 37.52 million shares as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-16
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 37.52M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 25.56M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 12.34M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 11.80M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 37.52M shares 10-K · filed 2026-03-16 |
| 2024-12-31 | 25.56M shares 10-K · filed 2026-03-16 |
| 2023-12-31 | 12.34M shares 10-K · filed 2025-03-18 |
| 2022-12-31 | 11.80M shares 10-K · filed 2024-03-11 |
| 2021-12-31 | 7.87M shares 10-K · filed 2023-03-09 |
| 2020-12-31 | 5.95M shares 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |